1426 related articles for article (PubMed ID: 36045691)
1. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma.
Zhang B; Wang Q; Zhang T; Zheng Z; Lin Z; Zhou S; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y
Front Cell Dev Biol; 2023; 11():1159355. PubMed ID: 37152283
[No Abstract] [Full Text] [Related]
6. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
7. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
Yang H; Yang J; Bian H; Wang X
Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
[TBL] [Abstract][Full Text] [Related]
8. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics.
Zhang Z; Wang B; Xu X; Xin T
Front Genet; 2022; 13():1036460. PubMed ID: 36386799
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
Li J; Yin J; Li W; Wang H; Ni B
Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma.
Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C
Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer.
Wang Y; Guo F; Song W; Guo W; Shao J; Liu Y
Heliyon; 2024 Jan; 10(2):e24411. PubMed ID: 38298669
[TBL] [Abstract][Full Text] [Related]
13. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
Front Genet; 2023; 14():1124439. PubMed ID: 36936439
[No Abstract] [Full Text] [Related]
14. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
16. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer.
Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F
J Oncol; 2022; 2022():5034092. PubMed ID: 36276275
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
18. Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model.
Cui J; Xiong Y; Liu Y; Sun M; Gu X; Zhong L; Hong X; Liu L
Biomed Res Int; 2022; 2022():7406636. PubMed ID: 36588537
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment.
Zhu L; Yuan F; Wang X; Zhu R; Guo W
Cancer Biomark; 2024 Mar; ():. PubMed ID: 38578883
[TBL] [Abstract][Full Text] [Related]
20. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
